fbpx
  • Home
  • Study Details
Open

iTBS for Adolescents

An open label, pilot, feasibility study for adolescents with major depression. The study treatment is Intermittent Theta Burst Stimulation, a shorter duration of Transcranial Magnetic Stimulation, commonly used in adults.

Age & Gender

  • 13 years ~ 17 years
  • Male, Female, Gender Inclusive

Visit Availability

  • Standard business hours (M-F, 8-5)
  • Extended hours (M-F, early morning or evening)

Location

North Carolina (Statewide)

What will be asked of you

There is a screening visit with questionnaires and medical history review to see if your child is eligible. If so, we will proceed to 20 treatment sessions, 4 weeks M-F of iTBS. Weekly during the treatment phase we will conduct cognitive and safety assessments. There are 3 follow up visits with questionnaires and medical review. There is no cost to participate if eligible.

In-person visits:
24
Total length of participation:
12 weeks

Looking for Specific Volunteers

Able to participate:

  • Major Depressive Disorder
  • Depression
  • Self-injurious behavior

Not eligible if:

  • Have cranial metallic implants
  • Bipolar
  • Psychosis
  • Seizures
  • Eating disorder

Contact the Team

Visit Location

Contact & Visit Location

Primary Contact

Primary Visit Location

Vilcom Center Dr, Chapel Hill, NC 27514, USA

Additional Study Information

Principal Investigator

Shahzad Ali
Psychiatry - General

Study Type

Clinical or Medical
Interventional

Study Topics

Behavior
Child and Teen Health
Mental and Emotional Health
Wellness and Lifestyle

IRB Number

19-1100

logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research
Research for Me logo

Copyright © 2013-2020 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.